stoxline Quote Chart Rank Option Currency Glossary
  
Cutera, Inc. (CUTR)
2.41  0.17 (7.59%)    03-01 16:00
Open: 2.3
High: 2.46
Volume: 1,055,854
  
Pre. Close: 2.24
Low: 2.11
Market Cap: 48(M)
Technical analysis
2024-03-01 4:51:41 PM
Short term     
Mid term     
Targets 6-month :  3.14 1-year :  3.71
Resists First :  2.69 Second :  3.18
Pivot price 2.63
Supports First :  1.89 Second :  1.58
MAs MA(5) :  2.36 MA(20) :  2.63
MA(100) :  2.9 MA(250) :  11.34
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  25.5 D(3) :  25.2
RSI RSI(14): 45.3
52-week High :  32.93 Low :  1.37
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CUTR ] has closed above bottom band by 29.9%. Bollinger Bands are 38.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.46 - 2.47 2.47 - 2.48
Low: 2.09 - 2.1 2.1 - 2.11
Close: 2.39 - 2.41 2.41 - 2.42
Company Description

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

Headline News

Fri, 01 Mar 2024
Premarket Mover: Cutera Inc (CUTR) Up 5.58% - InvestorsObserver

Wed, 28 Feb 2024
Do Analysts Agree Wednesday on Cutera Inc (CUTR) Stock's Target Price? - InvestorsObserver

Tue, 27 Feb 2024
Can Cutera Inc (CUTR) Stock Rise to the Top of Healthcare Sector Tuesday? - InvestorsObserver

Tue, 09 Jan 2024
CUTR Stock Quote Price and Forecast - CNN

Tue, 09 Jan 2024
Cutera stock gains on early 2023 results (NASDAQ:CUTR) - Seeking Alpha

Fri, 15 Dec 2023
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Cutera, Inc. (CUTR) Investigation - Barron's

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 20 (M)
Shares Float 17 (M)
Held by Insiders 4.5 (%)
Held by Institutions 91.4 (%)
Shares Short 6,950 (K)
Shares Short P.Month 5,120 (K)
Stock Financials
EPS -3.86
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -3.48
Profit Margin -31.1 %
Operating Margin -35.7 %
Return on Assets (ttm) -8.5 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -4.7 %
Gross Profit (p.s.) 0
Sales Per Share 12.3
EBITDA (p.s.) -2.77
Qtrly Earnings Growth 0 %
Operating Cash Flow -105 (M)
Levered Free Cash Flow -97 (M)
Stock Valuations
PE Ratio -0.63
PEG Ratio -0.1
Price to Book value -0.7
Price to Sales 0.19
Price to Cash Flow -0.46
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android